BBlogFlow

Surrey mother whose son died of a brain tumour welcomes new plans - BBC

·2d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email
Photo credit : A young boy wearing a pale blue shirt stands next to his mother

1 day agoJane TrumbleSouth EastEllie ThompsonBilly died 15 days before his fifth birthdayA mother whose son died of a brain tumour has welcomed government plans to speed up research into the disease. Ellie Thompson's son Billy passed away when he was four years old from an aggressive brain tumour. Speaking on BBC Radio Surrey, Ellie, from Great Bookham, praised Archie: "It is an honour to be alongside him and all the other amazing people that have lost someone or have brain tumours themselves. "That afternoon, Downing Street announced steps which it says means people living with brain cancer "will get a faster route from research to treatment". Ellie ThompsonBilly underwent radiotherapy treatment for his brain tumourEllie's son Billy was four years old when he died in her arms just five months after diagnosis. She said: "To be told there is nothing they can do apart from radiotherapy... it was hopeless. "Now Ellie says she and other campaigners are finally making change.

This article is an excerpt. To read the full content, visit the original source. BBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

'Justice for Destiny' walk held to remember Mi'kmaw woman whose life was cut short - CBC

Nova ScotiaCrowds gathered in Sipekne'katik on Sunday to remember Destiny Rennie, a 22-year-old Mi'kmaw woman who died of fungal meningitis three years ago. Her family has filed a lawsuit against the Nova Scotia Health Authority, saying her race played a role in the allegedly negligent medical treatment she received. Destiny Rennie was 22 when she died of fungal meningitis in 2023Yuan Wang · CBC News · Posted: Oct 06, 2026 4:32 PM EDT | Last Updated: October 6Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Oct. 4 marked the third annual Justice for Destiny memorial walk and was held at Sipekne’katik First Nation. (CBC News)People gathered at Sipekne'atik First Nation on Sunday for a memorial walk to remember a young Mi'kmaw woman and to highlight treatment of Indigenous people in the health-care system. Destiny Rennie was 22 when she died of fungal meningitis in 2023.

CBC·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·